Researchers from the University of Alabama at Birmingham published work in Modern Pathology highlighting six cases of chronic granulomatous fungal sinusitis. The article, titled “Histopathologic ...

How prevalent are fungal infections in the differential diagnosis of chronic sinusitis?—JANICE SKINNER, CRNP, Sykesville, Md. Fungal sinus infections occur primarily in immunosuppressed patients and ...

What Is Dupixent, and Why Does It Matter? Dupixent (dupilumab) is a prescription medicine for treating various allergic conditions and is given as a shot under the skin. The FDA has now approved ...

ST. LOUIS — A St. Lucian woman can breathe easier tonight thanks in part to a lifesaving surgery performed by doctors at St. Louis University Hospital. Berthia Mason travelled more than 2,500 miles ...

A new research perspective was published in Oncoscience (Volume 10) on May 27, 2023, entitled, "Think outside the box – atypical infections in chronic sinusitis." Inflammations of the paranasal ...

The FDA approval of the biologic drug Dupixent for allergic fungal rhinosinusitis may help patients living with this challenging condition and help them avoid repeat surgeries. The U.S. Food and Drug ...

“Most people breathe in fungal spores every day without getting sick. However, those with a weakened immune system are more at risk of developing an Invasive fungal sinusitis infection,” according to ...

Drs. Jessa Miller and Amrita Ray discuss the paradox of increasing incidence and decreasing mortality in AIFRS.

Add Yahoo as a preferred source to see more of our stories on Google. If you've ever experienced a sinus infection, you're all too familiar with the congestion, discharge, bad breath postnasal drip, ...

Priority Review approval extends dupilumab into AFRS with prior surgery, expanding sino-nasal indications beyond CRSwNP and representing the ninth FDA-approved indication across type 2 inflammatory ...

The U.S. Food and Drug Administration has approved Dupixent (dupilumab) for the treatment of adult and pediatric patients aged 6 years and older with allergic fungal rhinosinusitis (AFRS) and a ...